✨ 2 results found - Searched 21748 records in 3ms.
Tesis
Pengembangan Konjugat Cetuximab – Puromisin sebagai Imunotoksin untuk Menghambat Viabilitas Sel Kanker Payudara Tipe Triple Negative
2021 | BY Diah Puspitasari - Septelia Inawati Wanandi - Mohamad Sadikin- Development of cetuximab-puromycin conjugate as an immunotoxin to inhibit the viability of triple negative breast cancer cells.
- Nomor Panggil T21521fk
Tesis
Kesintasan Lima Tahun Kanker Payudara Tripel Negatif di RSCM dan Faktor Klinikopatogis yang Memengaruhinya
2020 | BY Ihza Fachriza - Erwin Danil Yulian- Five Years Survival of Triple Negative Breast Cancer in Cipto Mangunkusumo Hospital and Influencing Clinicopathological Factors.
- Nomor Panggil T20350fk